Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 165 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1641 5.6 months Recurrent or progressive malignant glioma 4 Chemotherapy
UCLA School of Medicine United States 5/2003
Treatment Details: Patients: This study involved 14 patients with progressive or recurrent malignant gliomas. Twelve had glioblastoma multiforme and 2 had anaplastic astrocytoma. Treatment: Treatment consi
 
1642 5.6 months Recurrent GBM 4 Biologic therapy
Chemotherapy
University of California San Francisco United States 4/2003
Treatment Details: Patients: This Phase II study involved a total of 121 patients with recurrent malignant gliomas. Eighty patients had glioblastoma multiforme and 41 patients had anaplastic glioma. Trea
 
1643 5.6 months Advanced NSCLC 4 Chemotherapy
Northwestern University Medical School United States 2/2003
Treatment Details: Patients: This Phase I/II trial involved 21 patients with advanced (stage IIIB or IV) non-small-cell lung cancer. The average age of the patients was 67. Treatment: The treatment consist
 
1644 5.5 months Inoperable hepatocellular (liver) carcinoma 5 Chemotherapy
Radiation
Ghent University Hospital Belgium 7/2002
Treatment Details: Patients: This trial involved 20 patients with inoperable hepatocellular (liver) carcinoma. Patients were evenly divided into two groups – 10 patients in group A and 10 patients in group B.
 
1645 5.5 months Advanced hepatocellular carcinoma 4 Biologic therapy
Yonsei University College of Medicine Korea 10/2013
Treatment Details: Patients: This study involved 226 advanced hepatocellular cancer patients with a median age of 57 years, 83.2% of whom were male. Treatment: Patients were treated with the biologic ther
 
1646 5.4 months Metastatic transitional cell carcinoma of the urinary tract 4 Chemotherapy
St Bartholomew’s Hospital United Kingdom 8/2013
Treatment Details: This phase 2 study involved 39 patients with metastatic transitional cell carcinoma of the urinary tract with a median age of 69 years. Patient gender information was not provided. Treat
 
1647 5.4 months Malignant pleural mesothelioma 4 Chemotherapy
Memorial Sloan Kettering Cancer Center United States 3/2014
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who were divided into two separate treatment groups. Group A consisted of 33 patients with a median age of 65 years; 7
 
1648 5.4 months Advanced melanoma 4 Chemotherapy
Immunotherapy
University of Chicago United States 2/2010
Treatment Details: Patients: This study involved 19 patients with previously treated advanced melanoma. The median patient age was 63 years and 63% were male. Treatment: Patients were treated with the ch
 
1649 5.4 months Metastatic Breast Cancer 5 Biologic therapy
Hematology and Oncology Specialists United States 2/2015
Treatment Details: Patients: This phase 2 study involved 34 human epidermal growth factor receptor 2epositive (HER2+) metastatic breast cancer patients who had received prior treatment with trastuzumab. The
 
1650 5.4 months Recurrent GBM 4 Chemotherapy
The Royal Marsden Hospital, Surrey United Kingdom 1/2001
Treatment Details: Patients: This Phase II study involved 126 patients with relapsed glioblastoma multiforme. (There were 12 other patients with different cancer types.) Treatment: The treatment consisted
 
Page 165 of 187  | Previous Page  | Next Page